Back
Denali Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison
Sell
18
DNLI
Denali Therapeutics
Last Price:
$20.88
Seasonality Move:
-14.4%
Sell
30
CATX
Perspective Therapeutics
Last Price:
$3.32
Seasonality Move:
36.42%
Sell
18
Denali Therapeutics (DNLI)
is a Sell
Is Denali Therapeutics a Buy, Sell or Hold?
-
The current Denali Therapeutics [DNLI] share price is $20.38. The Score for DNLI is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
-
DNLI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
-
The current Perspective Therapeutics [CATX] share price is $3.19. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $20.38Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNLI is experiencing slight selling pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $3.19Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight buying pressure.
DNLI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.37 | Sell |
Relative Strength Index (14 RSI): | 30.62 | Sell |
Chaikin Money Flow: | -66741 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.33 - 24.73) | Sell |
Bollinger Bands (100): | (23.02 - 28.68) | Sell |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.94 | Sell |
Relative Strength Index (14 RSI): | 29.96 | Sell |
Chaikin Money Flow: | 455171 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.08 - 3.96) | Sell |
Bollinger Bands (100): | (5.8 - 14.84) | Sell |
DNLI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.9 | Sell |
20-day SMA: | 22.53 | Sell |
50-day SMA: | 25.08 | Sell |
200-day SMA: | 23.05 | Sell |
8-day EMA: | 21.02 | Sell |
20-day EMA: | 22.34 | Sell |
50-day EMA: | 24.16 | Sell |
200-day EMA: | 23.91 | Sell |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.1 | Buy |
20-day SMA: | 3.37 | Sell |
50-day SMA: | 6.84 | Sell |
200-day SMA: | 11.96 | Sell |
8-day EMA: | 3.18 | Buy |
20-day EMA: | 3.74 | Sell |
50-day EMA: | 6.16 | Sell |
200-day EMA: | 9.62 | Sell |
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.15 per share, and an increase next year of $1.00 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and a decrease next year of $0.35 per share.
Denali Therapeutics Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |